Welcome to the Stocktwits Top 25 Newsletter for Week 31 of 2022!
The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD) and tracks their performances over time.
Here are the Stocktwits Top 25 Lists for Week 31:
ST Top 25 S&P 500
The S&P 500 Top 25 list (-1.86%) underperformed the S&P 500 index (+0.36%).
There were five major changes to the list this week.
Corteva Inc. (+0.61%), Jack Henry & Associates (+1.59%), Huntington Ingalls Industries (+4.95%), Quanta Services (-1.31%), and Archer-Daniels-Midland (-0.01%) joined the list.
They replaced Sempra Energy (-3.62%), Pioneer Natural Resources (-8.36%), Molson Coors Beverage Co. (-9.51%), APA Corp. (-14.58%), and Solaredge Technologies (-12.39%).
Energy stocks lagged this week but remain near the top YTD performers. The lower end of the list continues to churn week after week.
Check out how the momentum meter has performed vs. the S&P 500 index this year:
The Large-Cap Nasdaq 100
The Nasdaq 100 Top 25 list (+1.05%) underperformed the Nasdaq 100 index (+2.01%).
There were two major changes to the list this week.
Analog Devices (+3.08%) and Regeneron Pharmaceuticals (+5.49%) joined the list.
They replaced Monster Beverage Corp. (-8.27%) and Mondelez International (-0.42%).
The Nasdaq 100 list generally has the least movement each week, and this week is no exception.
The Growth-Centric Russell 2000
The Russell 2000 Top 25 list (+10.45%) significantly outperformed the Russell 2000 index (+1.94%).
There were six major changes to the list this week.
Global Blood Therapeutics (+95.11%), Rhythm Pharmaceuticals (+60.63%), Universal Logistics (+16.47%), Geron Corp. (+27.37%), Mirum Pharmaceuticals (+17.29%), and Allegheny Technologies (+16.59%) joined the list.
They replaced Range Resources (-7.05%), Helmerich & Payne (-12.85%), Patterson UTI Energy (-13.17%), Kosmos Energy (-6.15%), Valhi Inc. (-19.82%), and Evolus Inc. (-23.76%).
Biotechnology stocks were a clear standout this week as the sector continued its run. Meanwhile, several energy stocks were knocked off the list.
ST Top 25 TOP DAWG OF THE WEEK 🐶
The Top 25 lists’ Top Dawg was Global Blood Therapeutics, which rallied 95.11%.
It can be difficult to know exactly why a stock is trending, but not this week.
Global Blood Therapeutics rallied after the Wall Street Journal reported Pfizer is in advanced talks to buy the drugmaker for $5 billion.
The company’s treatment for sickle cell disease received U.S. approval in 2019, and its pipeline of drugs makes it a prime target for a cash-flush Pfizer.
$GBT is up 109.59% YTD.
See Y’all Next Week 🤙